CD8A and neoplasm: Prostate cancers from Klf4(f/f) or Klf4(f/f);Lys-Cre mice were analyzed for CD3, CD4 and CD8 tumor-infiltrating lymphocytes (TIL) on day 21 (Fig 5A).